Newspaper Publication for Standalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has published its standalone unaudited financial results for the quarter and half year ended 30 September 2025 in two newspapers — The Free Press Journal (English) and Navshakti (Marathi) — on 29 October 2025. The Board of Directors approved these results at their meeting held on 28 October 2025. This filing is submitted to BSE under SEBI Listing Regulations 33 and 47(1), which require companies to publish quarterly results in newspapers. The actual financial numbers are not contained in this filing; they were filed separately with BSE earlier and are also available on the company's website and www.bseindia.com. The intimation is signed by Ashish U. Bhuta, Chairman & Managing Director (DIN: 00226479).
This is a routine regulatory compliance filing with no new financial information beyond what was already disclosed. Shareholders looking for the actual Q2/H1 FY26 numbers should refer to the results filed with BSE on 28 October 2025. No immediate stock price trigger is expected from this specific filing.